UniDoc Signs Definitive Agreement to Provide Telehealth Services in Kenya
VANCOUVER, British Columbia, Aug. 11, 2022 (GLOBE NEWSWIRE) — UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) (“UniDoc,” or the “Company”), an…
VANCOUVER, British Columbia, Aug. 11, 2022 (GLOBE NEWSWIRE) — UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) (“UniDoc,” or the “Company”), an…
Columvi is the first CD20xCD3 T-cell-engaging bispecific antibody available in Europe to treat the most common and aggressive form of lymphoma Approval…
LAUSANNE, Switzerland, July 11, 2023 (GLOBE NEWSWIRE) — ADC Therapeutics SA (NYSE: ADCT) today announced a voluntary pause in the enrollment of new…
First Phase 3 Trial Evaluating Monotherapy with a Cardiac Myosin Inhibitor Compared to Monotherapy with a Beta Blocker in Adults with Symptomatic…
Study finds unique hyperbaric oxygen therapy protocol is effective for patients suffering with cardiac dysfunction due to post-COVID-19…
Study finds unique hyperbaric oxygen therapy protocol is effective for patients suffering with cardiac dysfunction due to post-COVID-19…
Study finds unique hyperbaric oxygen therapy protocol is effective for patients suffering with cardiac dysfunction due to post-COVID-19…
Study finds unique hyperbaric oxygen therapy protocol is effective for patients suffering with cardiac dysfunction due to post-COVID-19…
Study finds unique hyperbaric oxygen therapy protocol is effective for patients suffering with cardiac dysfunction due to post-COVID-19…
Study finds unique hyperbaric oxygen therapy protocol is effective for patients suffering with cardiac dysfunction due to post-COVID-19…
Study finds unique hyperbaric oxygen therapy protocol is effective for patients suffering with cardiac dysfunction due to post-COVID-19…